Novartis Consumer Health Inc. has partnered with the Emerson Group to bolster marketing and promotional support for over a dozen of its niche over-the-counter medicine and personal care brands.
Ron Lombardi has been appointed chief financial officer of over-the-counter health and household products marketer Prestige Brands Holdings Inc. Prestige Brands said late Thursday that Lombardi will take over the CFO post on Dec. 6.
Merck & Co. has unveiled an agreement to buy SmartCells Inc., a private company developing a unique technology for the treatment of diabetes. Under the deal announced Thursday, Merck said it plans to acquire all outstanding stock of Beverly, Mass.-based SmartCells.
Endo Pharmaceuticals said this week that it has completed its acquisition of generic drug maker Qualitest Pharmaceuticals. Endo had announced in late September that it entered into an agreement to acquire Qualitest for about $1.2 billion in cash.
Eastman Kodak Co. has introduced its new PYNK Smart Print System photo kiosks at 5,000 CVS/pharmacy stores nationwide.
Carma Laboratories Inc., the maker of Carmex lip balm, has unveiled two limited-edition flavors, Carmex Lime Twist and Carmex Vanilla Click Sticks.
Watson Pharmaceuticals Inc. announced that its oral emergency contraceptive, ella (ulipristal acetate 30 mg) is now available by prescription in the United States.
VIA Group has partnered with Prestige Brands Holdings Inc. to launch an integrated marketing and promotional campaign for the PediaCare line of over-the-counter children’s remedies.
Pfizer Consumer Healthcare has rolled out Caltrate Soft Chews, which the company bills as a great-tasting and convenient way to meet the recommended daily intake of vitamin D to maintain bone health.
Merck & Co. president Kenneth Frazier has been named chief executive officer, succeeding current CEO Richard Clark, who will continue as chairman. The pharmaceutical giant said Tuesday that Frazier, 55, will take the CEO reins effective Jan. 1. He also will become a member of the company’s board.
Cardinal Health Inc. has wrapped up a $470 million deal to acquire Zuellig Pharma China, a leading health care distribution business in China, known locally as Yong Yu, and the nation’s largest pharmaceutical importer.
Procter & Gamble Co.’s Crest Oral-B brand duo is introducing the Clinical Pro-Health System for Gingivitis, a product set that according to the company is clinically tested to virtually eliminate gingivitis.
Perrigo has launched Naproxen Sodium Soft Gels and, via its licensor and supplier Synthon, levocetirizine allergy tablets. The company said Monday that the Naproxen Sodium Soft Gels are the generic equivalent of Bayer HealthCare’s Aleve Liquid Gels (220 mg), an over-the-counter analgesic.
Energizer Holdings Inc. has closed its acquisition of American Safety Razor Co. Energizer said late Tuesday that under the transaction it is acquiring substantially all of the assets of American Safety Razor for $301 million in cash and the assumption of certain liabilities.
GlaxoSmithKline PLC has agreed to the sale of its United States oral penicillin facility and product portfolio to Dr. Reddy’s Laboratories. Dr. Reddy’s said Tuesday that under the agreement, GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tenn.
Par Pharmaceutical Companies Inc. and Dr. Reddy’s Laboratories have released generic versions of AstraZeneca’s Accolate asthma drug in the United States. Par said Monday that it has entered into an exclusive U.S.
